MyD88 Primes Macrophages for Full-Scale Activation by Interferon-γ yet Mediates Few Responses to Mycobacterium tuberculosis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Macrophages are activated from a resting state by a combination of cytokines and microbial products. Microbes are often sensed through Toll-like receptors signaling through MyD88. We used large-scale microarrays in multiple replicate experiments followed by stringent statistical analysis to compare gene expression in wild-type (WT) and MyD88−/− macrophages. We confirmed key results by quantitative reverse transcription polymerase chain reaction, Western blot, and enzyme-linked immunosorbent assay. Surprisingly, many genes, such as inducible nitric oxide synthase, IRG-1, IP-10, MIG, RANTES, and interleukin 6 were induced by interferon (IFN)-γ from 5- to 100-fold less extensively in MyD88−/− macrophages than in WT macrophages. Thus, widespread, full-scale activation of macrophages by IFN-γ requires MyD88. Analysis of the mechanism revealed that MyD88 mediates a process of self-priming by which resting macrophages produce a low level of tumor necrosis factor. This and other factors lead to basal activation of nuclear factor κB, which synergizes with IFN-γ for gene induction. In contrast, infection by live, virulent Mycobacterium tuberculosis (Mtb) activated macrophages largely through MyD88-independent pathways, and macrophages did not need MyD88 to kill Mtb in vitro. Thus, MyD88 plays a dynamic role in resting macrophages that supports IFN-γ–dependent activation, whereas macrophages can respond to a complex microbial stimulus, the tubercle bacillus, chiefly by other routes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
Self-citationThe many faces of macrophage activation
Mosser, D. M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602325 · Cited by 1,902
Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis
Means, T. K., Wang, S., Lien, E., Yoshimura, A., Golenbock, D. T., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3920 · Cited by 804 · cited 3×
“Mycobacterial cell wall glycolipid lipoarabinomannan (LAM), mannosylated phosphatidylinositol, and a 19-kD Mtb lipoprotein were characterized as TLR2 agonists, whereas an undefined cell-associated and heat-labile moiety of live Mtb acted via TLR4 (25, 26).”
Background
Cited by
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2
Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J., Tracey, K. J., & Yang, H. (2006) · Shock · doi:10.1097/01.shk.0000225404.51320.82 · Cited by 832
“Bone marrowYderived macrophages were isolated and differentiated matured to macrophages in 20% L-cell medium as previously described (25).”
MethodSelf-citationPivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
Tang, S.-C., Arumugam, T. V., Xu, X., Cheng, A., Mughal, M. R., Jo, D. G., Lathia, J. D., Siler, D. A., Chigurupati, S., Ouyang, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702553104 · Cited by 779
Bafica, A., Scanga, C. A., Feng, C. G., Leifer, C., Cheever, A., & Sher, A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051782 · Cited by 601
RICK/RIP2 Mediates Innate Immune Responses Induced through Nod1 and Nod2 but Not TLRs
Park, J.-H., Kim, Y.-G., McDonald, C., Kanneganti, T.-D., Hasegawa, M., Body-Malapel, M., Inohara, N., & Núñez, G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2380 · Cited by 530
The role of IL-10 in immune regulation during M. tuberculosis infection
Redford, P. S., Murray, P. J., & O'Garra, A. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.7 · Cited by 472
Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein with Host Epithelium
Volkman, H. E., Pozos, T. C., Zheng, J., Davis, J. M., Rawls, J. F., & Ramakrishnan, L. (2010) · Science · doi:10.1126/science.1179663 · Cited by 448
Innate Immune Recognition of Mycobacterium tuberculosis
Kleinnijenhuis, J., Oosting, M., Joosten, L. A. B., Netea, M. G., & Van Crevel, R. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/405310 · Cited by 414
NOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosis
Ferwerda, G., Girardin, S. E., Kullberg, B.-J., Le Bourhis, L., de Jong, D. J., Langenberg, D. M. L., van Crevel, R., Adema, G. J., Ottenhoff, T. H. M., Van der Meer, J. W. M., et al. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010034 · Cited by 365
Jo, E.-K., Yang, C.-S., Choi, C. H., & Harding, C. V. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00914.x · Cited by 331
Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88
Fremond, C. M., Yeremeev, V., Nicolle, D. M., Jacobs, M., Quesniaux, V. F., & Ryffel, B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421027 · Cited by 318
Immunology of Mycobacterium tuberculosis Infections
Sia, J. K., & Rengarajan, J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0022-2018 · Cited by 312
Netea, M. G., Van der Graaf, C., Van der Meer, J. W. M., & Kullberg, B. J. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1103543 · Cited by 312
Negishi, H., Fujita, Y., Yanai, H., Sakaguchi, S., Ouyang, X., Shinohara, M., Takayanagi, H., Ohba, Y., Taniguchi, T., & Honda, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607181103 · Cited by 310
On regulation of phagosome maturation and antigen presentation
Blander, J. M., & Medzhitov, R. (2006) · Nature Immunology · doi:10.1038/ni1006-1029 · Cited by 310
Can innate immunity be enhanced to treat microbial infections?
Finlay, B. B., & Hancock, R. E. W. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro908 · Cited by 298
O'Connor, J. C., Lawson, M. A., André, C., Briley, E. M., Szegedi, S. S., Lestage, J., Castanon, N., Herkenham, M., Dantzer, R., & Kelley, K. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802722 · Cited by 295
Toll-like receptor pathways in the immune responses to mycobacteria
Quesniaux, V., Fremond, C., Jacobs, M., Parida, S., Nicolle, D., Yeremeev, V., Bihl, F., Erard, F., Botha, T., Drennan, M., et al. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.04.016 · Cited by 281
MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival
Kim, Y., Zhou, P., Qian, L., Chuang, J.-Z., Lee, J., Li, C., Iadecola, C., Nathan, C., & Ding, A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070868 · Cited by 234
Self-citationThe adaptor molecule CARD9 is essential for tuberculosis control
Dorhoi, A., Desel, C., Yeremeev, V., Pradl, L., Brinkmann, V., Mollenkopf, H.-J., Hanke, K., Gross, O., Ruland, J., & Kaufmann, S. H. E. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20090067 · Cited by 200
“PRRs involved in MTB recognition not only use MyD88-dependent, but also MyD88-independent pathways (Shi et al., 2003; Fortune et al., 2004; Schnappinger et al., 2006), and therefore additional adaptors await identification.”
BackgroundThe proinflammatory cytokine-induced IRG1 protein associates with mitochondria
Degrandi, D., Hoffmann, R., Beuter-Gunia, C., & Pfeffer, K. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0013 · Cited by 155
Toll-like receptor signaling in the lysosomal pathways
Sanjuan, M. A., Milasta, S., & Green, D. R. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00732.x · Cited by 137
“Considering that at least 578 genes are differently expressed in MyD88 ⁄ ) cells with respect to wildtype (51) and that phagosome maturation was reduced even with the control beads, it was concluded that the defect in phagosome maturation in MyD88 ⁄ ) macrophages is determined developmentally (50).”
BackgroundA role for IL‐18 in protective immunity against Mycobacterium tuberculosis
Schneider, B. E., Korbel, D., Hagens, K., Koch, M., Raupach, B., Enders, J., Kaufmann, S. H. E., Mittrücker, H., & Schaible, U. E. (2010) · European Journal of Immunology · doi:10.1002/eji.200939583 · Cited by 115
“MyD88 has been implicated in IFN-γ receptor signalling [37-39].”
Kurtz, S., McKinnon, K. P., Runge, M. S., Ting, J. P.-Y., & Braunstein, M. (2006) · Infection and Immunity · doi:10.1128/iai.01022-06 · Cited by 114
Fernandez-Boyanapalli, R., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Dinauer, M. C., Riches, D. W. H., Henson, P. M., Byrne, A., & Bratton, D. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001778 · Cited by 99
Kannan, S., Audet, A., Huang, H., Chen, L.-J., & Wu, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2396 · Cited by 80
The role of toll-like receptors in macrophages
McCoy, C. (2008) · Frontiers in Bioscience · doi:10.2741/2660 · Cited by 69
Metadata
- Authors
- Shi, S., Nathan, C., Schnappinger, D., Drenkow, J., Fuortes, M., Block, E., Ding, A., Gingeras, T. R., Schoolnik, G., Akira, S., Takeda, K., & Ehrt, S.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-09-29
- Volume
- 198
- Issue
- 7
- Pages
- 987-997
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2119910602
- Cited by
- 146
- References
- 4
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.